It will be very interesting to further investigate how ALDH1A1 is only activated by TAZ in CSCs and whether high levels of TAZ is positively correlated with those of ALDH1A1 (CSC-specific) in clinical lung cancer patients. The gene discussed is ALDH1A1; the disease is lung cancer.